中国初级卫生保健
中國初級衛生保健
중국초급위생보건
CHINESE PRIMARY HEALTH CARE
2009年
7期
92-93
,共2页
晚期乳腺癌%多西他赛%表阿霉素
晚期乳腺癌%多西他賽%錶阿黴素
만기유선암%다서타새%표아매소
advanced breast cancer%docetaxel%epirubicin
目的 观察多西他赛联合表阿霉素治疗晚期乳腺癌的临床疗效及毒副作用,并对其安全性进行评估.方法 用多西他赛联合表阿霉素治疗晚期乳腺癌患者41例,其中初治患者18例,复治患者23例.结果 41例患者中,3例达到完全缓解,21例部分缓解,9例病情稳定,8例出现进展,其中有效率达58.5%,临床获益率达80.5%.结论 多西他赛联合表阿霉素对晚期乳腺癌具有较好的疗效和耐受性,可作为晚期乳腺癌的解救方案.
目的 觀察多西他賽聯閤錶阿黴素治療晚期乳腺癌的臨床療效及毒副作用,併對其安全性進行評估.方法 用多西他賽聯閤錶阿黴素治療晚期乳腺癌患者41例,其中初治患者18例,複治患者23例.結果 41例患者中,3例達到完全緩解,21例部分緩解,9例病情穩定,8例齣現進展,其中有效率達58.5%,臨床穫益率達80.5%.結論 多西他賽聯閤錶阿黴素對晚期乳腺癌具有較好的療效和耐受性,可作為晚期乳腺癌的解救方案.
목적 관찰다서타새연합표아매소치료만기유선암적림상료효급독부작용,병대기안전성진행평고.방법 용다서타새연합표아매소치료만기유선암환자41례,기중초치환자18례,복치환자23례.결과 41례환자중,3례체도완전완해,21례부분완해,9례병정은정,8례출현진전,기중유효솔체58.5%,림상획익솔체80.5%.결론 다서타새연합표아매소대만기유선암구유교호적료효화내수성,가작위만기유선암적해구방안.
OBJECTIVE To evaluate the affieacy, toxicity and safety of docetaxel and epirubicin in the treatment of advanced breast caner. METHODS A total of 41 patients with advanced breast cancer proved pathologically were treated on with docetaxel and epirubicin regimen, among whom 18 patients were subjected to initially treatment, other 23 to reteatment. RESULTS Of the 41 patients, 3 achieved CR, 21 PR, 9 SD and 8 PD, with a response rate of 58.5% and 80.5%. CONCLUSIONS The regimen of docetaxel and epirubicin .is effective and weU-tolerated in the treatment of advanced breast cancer. It may be a relevant regimen for patients.
